VIOLA, DAVID Statistiche
VIOLA, DAVID
Outcomes of the Tall-Cell Variant of Papillary Thyroid Carcinoma in Patients with Different Ages: A 17-YearMono-Institutional Experience
2023-01-01 Proietti, A; Signorini, F; Giannini, R; Poma, Ma; Macerola, E; Torregrossa, L; Materazzi, G; Basolo, A; Santini, F; Elisei, R; Viola, D; Basolo, F; Ugolini, C
Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA)
2022-01-01 Ho, Alan L; Dedecjus, Marek; Wirth, Lori J; Tuttle, R Michael; Inabnet, William B; Tennvall, Jan; Vaisman, Fernanda; Bastholt, Lars; Gianoukakis, Andrew G; Rodien, Patrice; Paschke, Ralf; Elisei, Rossella; Viola, David; So, Karen; Carroll, Danielle; Hovey, Tina; Thakre, Bhavana; Fagin, James A
Active surveillance in ret gene carriers belonging to families with multiple endocrine neoplasia
2021-01-01 Prete, A.; Matrone, A.; Gambale, C.; Bottici, V.; Cappagli, V.; Romei, C.; Torregrossa, L.; Valerio, L.; Minaldi, E.; Campopiano, M. C.; Lorusso, L.; Agate, L.; Molinaro, E.; Viola, D.; Ramone, T.; Mule, C.; Ciampi, R.; Basolo, F.; Elisei, R.
BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer
2021-01-01 Tao, Y.; Wang, F.; Shen, X.; Zhu, G.; Liu, R.; Viola, D.; Elisei, R.; Puxeddu, E.; Fugazzola, L.; Colombo, C.; Jarzab, B.; Czarniecka, A.; Lam, A. K.; Mian, C.; Vianello, F.; Yip, L.; Riesco-Eizaguirre, G.; Santisteban, P.; O'Neill, C. J.; Sywak, M. S.; Clifton-Bligh, R.; Bendlova, B.; Sykorova, V.; Zhao, S.; Wang, Y.; Xing, M.
Ca19.9 positivity and doubling time are prognostic factors of mortality in patients with advanced medullary thyroid cancer with no evidence of structural disease progression according to RECIST
2021-01-01 Lorusso, Loredana; Romei, Cristina; Piaggi, Paolo; Fustini, Chiara; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Viola, David; Pellegrini, Giovanni; Elisei, Rossella
Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates
2021-01-01 Lorusso, L.; Pieruzzi, L.; Gabriele, M.; Nisi, M.; Viola, D.; Molinaro, E.; Bottici, V.; Elisei, R.; Agate, L.
Prevalence and Risk Factors of Developing Fistula or Organ Perforation in Patients Treated with Lenvatinib for Radioiodine-Refractory Thyroid Cancer
2021-01-01 Valerio, L.; Giani, C.; Agate, L.; Molinaro, E.; Viola, D.; Bottici, V.; Matrone, A.; Puleo, L.; Lorusso, L.; Cappagli, V.; Ribechini, A.; Elisei, R.
Tall cell percentage alone in PTC without aggressive features should not guide patients’ clinical management
2021-01-01 Poma, A. M.; Viola, D.; Macerola, E.; Proietti, A.; Molinaro, E.; de Vietro, D.; Elisei, R.; Materazzi, G.; Miccoli, P.; Basolo, F.; Ugolini, C.
Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center
2020-01-01 Molinaro, Eleonora; Campopiano, Maria Cristina; Pieruzzi, Letizia; Matrone, Antonio; Agate, Laura; Bottici, Valeria; Viola, David; Cappagli, Virginia; Valerio, Laura; Giani, Carlotta; Puleo, Luciana; Lorusso, Loredana; Piaggi, Paolo; Torregrossa, Liborio; Basolo, Fulvio; Vitti, Paolo; Tuttle, R Michael; Elisei, Rossella
BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma
2020-01-01 Kim, K. J.; Kim, S. G.; Tan, J.; Shen, X.; Viola, D.; Elisei, R.; Puxeddu, E.; Fugazzola, L.; Colombo, C.; Jarzab, B.; Czarniecka, A.; Lam, A. K.; Mian, C.; Vianello, F.; Yip, L.; Riesco-Eizaguirre, G.; Santisteban, P.; O'Neill, C. J.; Sywak, M. S.; Clifton-Bligh, R.; Bendlova, B.; Sykorova, V.; Xing, M.
MON-490 Calcitonin-Based Thyroidectomy Is a Safe Approach in Patients with Germline RET Mutation and Permits to Delay Surgery in Children
2020-01-01 Prete, A; Romei, C; Tacito, A; Ramone, T; Bottici, V; Cappagli, V; Viola, D; Matrone, A; Agate, L; Lorusso, L; Valerio, L; Giani, C; Puleo, L; Molinaro, E; Elisei, R.
MON-524 Prospective Evaluation of Patients with Encapsulated Classical Variant of Papillary Thyroid Cancer and Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Have They A Similar Prognosis?
2020-01-01 Giani, C; Torregrossa, L; Ugolini, C; Ramone, T; Romei, C; Matrone, A; Viola, D; Molinaro, E; Materazzi, G; Basolo, F; Elisei, R.
MON-537 Primary Adrenal Insufficiency During Tyrosine Kinase Inhibitors Treatment in Advanced Thyroid Cancer Patients
2020-01-01 Valerio, L; Matrone, A; Agate, L; Bottici, V; Viola, D; Cappagli, V; Giani, C; Molinaro, E; Elisei, R.
No difference in the outcome of metastatic thyroid cancer patients when using recombinant or endogenous TSH
2020-01-01 Campopiano, Maria Cristina; Podestà, Debora; Bianchi, Francesca; Giani, Carlotta; Agate, Laura; Bottici, Valeria; Cappagli, Virginia; Lorusso, Loredana; Matrone, Antonio; Puleo, Luciana; Valerio, Laura; Viola, David; Piaggi, Paolo; Elisei, Rossella; Molinaro, Eleonora
OR21-01 Pre-Operative Calcitonin Value as a Predictive Factor of Cancer Related Death in Sporadic Medullary Thyroid Carcinoma
2020-01-01 Matrone, A; Cappagli, V; Donati, Ds; Prete, A; Valerio, L; Giani, C; Bottici, V; Viola, D; Agate, L; Molinaro, E; Vitti, P; Elisei, R.
Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up
2020-01-01 Giani, C; Torregrossa, L; Piaggi, P; Matrone, A; Viola, D; Molinaro, E; Agate, L; Romei, C; Ugolini, C; De Napoli, L; Materazzi, G; Basolo, F; Elisei, R
Proteinuria is a late-onset adverse event in patients treated with cabozantinib
2020-01-01 Cappagli, V; Moriconi, D; Bonadio, A G; Giannese, D; La Manna, Gaetano; Egidi, M Francesca; Comai, G; Vischini, G; Bottici, V; Elisei, R; Viola, D
Role Of Prophylactic Central Compartment Lymph Node Dissection On The Outcome Of Patients With Papillary Thyroid Carcinoma And Synchronous Ipsilateral Cervical Lymph Node Metastases
2020-01-01 De Napoli, Luigi; Matrone, Antonio; Favilla, Karin; Piaggi, Paolo; Galleri, David; Ambrosini, Carlo Enrico; Aghababyan, Alexander; Papini, Piermarco; Valerio, Laura; Viola, David; Torregrossa, Liborio; Ugolini, Clara; Proietti, Agnese; Basolo, Fulvio; Miccoli, Paolo; Elisei, Rossella; Materazzi, Gabriele
Thyroglobulin changes are highly dependent on TSH in low-risk DTC patients not treated with 131I
2020-01-01 Matrone, Antonio; Faranda, Alessio; Latrofa, Francesco; Gambale, Carla; Stefani Donati, Delio; Molinaro, Eleonora; Agate, Laura; Viola, David; Piaggi, Paolo; Torregrossa, Liborio; Basolo, Fulvio; Elisei, Rossella
A rare adverse event (AE) in a group of radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) patients in therapy with lenvatinib.
2019-01-01 Puleo, Luciana; Giani, Carlotta; Valerio, Laura; Viola, David; Molinaro, Eleonora; Elisei, Rossella; Agate, Laura
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Outcomes of the Tall-Cell Variant of Papillary Thyroid Carcinoma in Patients with Different Ages: A 17-YearMono-Institutional Experience | 1-gen-2023 | Proietti, A; Signorini, F; Giannini, R; Poma, Ma; Macerola, E; Torregrossa, L; Materazzi, G; Basolo, A; Santini, F; Elisei, R; Viola, D; Basolo, F; Ugolini, C | |
| Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA) | 1-gen-2022 | Ho, Alan L; Dedecjus, Marek; Wirth, Lori J; Tuttle, R Michael; Inabnet, William B; Tennvall, Jan; Vaisman, Fernanda; Bastholt, Lars; Gianoukakis, Andrew G; Rodien, Patrice; Paschke, Ralf; Elisei, Rossella; Viola, David; So, Karen; Carroll, Danielle; Hovey, Tina; Thakre, Bhavana; Fagin, James A | |
| Active surveillance in ret gene carriers belonging to families with multiple endocrine neoplasia | 1-gen-2021 | Prete, A.; Matrone, A.; Gambale, C.; Bottici, V.; Cappagli, V.; Romei, C.; Torregrossa, L.; Valerio, L.; Minaldi, E.; Campopiano, M. C.; Lorusso, L.; Agate, L.; Molinaro, E.; Viola, D.; Ramone, T.; Mule, C.; Ciampi, R.; Basolo, F.; Elisei, R. | |
| BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer | 1-gen-2021 | Tao, Y.; Wang, F.; Shen, X.; Zhu, G.; Liu, R.; Viola, D.; Elisei, R.; Puxeddu, E.; Fugazzola, L.; Colombo, C.; Jarzab, B.; Czarniecka, A.; Lam, A. K.; Mian, C.; Vianello, F.; Yip, L.; Riesco-Eizaguirre, G.; Santisteban, P.; O'Neill, C. J.; Sywak, M. S.; Clifton-Bligh, R.; Bendlova, B.; Sykorova, V.; Zhao, S.; Wang, Y.; Xing, M. | |
| Ca19.9 positivity and doubling time are prognostic factors of mortality in patients with advanced medullary thyroid cancer with no evidence of structural disease progression according to RECIST | 1-gen-2021 | Lorusso, Loredana; Romei, Cristina; Piaggi, Paolo; Fustini, Chiara; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Viola, David; Pellegrini, Giovanni; Elisei, Rossella | |
| Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates | 1-gen-2021 | Lorusso, L.; Pieruzzi, L.; Gabriele, M.; Nisi, M.; Viola, D.; Molinaro, E.; Bottici, V.; Elisei, R.; Agate, L. | |
| Prevalence and Risk Factors of Developing Fistula or Organ Perforation in Patients Treated with Lenvatinib for Radioiodine-Refractory Thyroid Cancer | 1-gen-2021 | Valerio, L.; Giani, C.; Agate, L.; Molinaro, E.; Viola, D.; Bottici, V.; Matrone, A.; Puleo, L.; Lorusso, L.; Cappagli, V.; Ribechini, A.; Elisei, R. | |
| Tall cell percentage alone in PTC without aggressive features should not guide patients’ clinical management | 1-gen-2021 | Poma, A. M.; Viola, D.; Macerola, E.; Proietti, A.; Molinaro, E.; de Vietro, D.; Elisei, R.; Materazzi, G.; Miccoli, P.; Basolo, F.; Ugolini, C. | |
| Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center | 1-gen-2020 | Molinaro, Eleonora; Campopiano, Maria Cristina; Pieruzzi, Letizia; Matrone, Antonio; Agate, Laura; Bottici, Valeria; Viola, David; Cappagli, Virginia; Valerio, Laura; Giani, Carlotta; Puleo, Luciana; Lorusso, Loredana; Piaggi, Paolo; Torregrossa, Liborio; Basolo, Fulvio; Vitti, Paolo; Tuttle, R Michael; Elisei, Rossella | |
| BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma | 1-gen-2020 | Kim, K. J.; Kim, S. G.; Tan, J.; Shen, X.; Viola, D.; Elisei, R.; Puxeddu, E.; Fugazzola, L.; Colombo, C.; Jarzab, B.; Czarniecka, A.; Lam, A. K.; Mian, C.; Vianello, F.; Yip, L.; Riesco-Eizaguirre, G.; Santisteban, P.; O'Neill, C. J.; Sywak, M. S.; Clifton-Bligh, R.; Bendlova, B.; Sykorova, V.; Xing, M. | |
| MON-490 Calcitonin-Based Thyroidectomy Is a Safe Approach in Patients with Germline RET Mutation and Permits to Delay Surgery in Children | 1-gen-2020 | Prete, A; Romei, C; Tacito, A; Ramone, T; Bottici, V; Cappagli, V; Viola, D; Matrone, A; Agate, L; Lorusso, L; Valerio, L; Giani, C; Puleo, L; Molinaro, E; Elisei, R. | |
| MON-524 Prospective Evaluation of Patients with Encapsulated Classical Variant of Papillary Thyroid Cancer and Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Have They A Similar Prognosis? | 1-gen-2020 | Giani, C; Torregrossa, L; Ugolini, C; Ramone, T; Romei, C; Matrone, A; Viola, D; Molinaro, E; Materazzi, G; Basolo, F; Elisei, R. | |
| MON-537 Primary Adrenal Insufficiency During Tyrosine Kinase Inhibitors Treatment in Advanced Thyroid Cancer Patients | 1-gen-2020 | Valerio, L; Matrone, A; Agate, L; Bottici, V; Viola, D; Cappagli, V; Giani, C; Molinaro, E; Elisei, R. | |
| No difference in the outcome of metastatic thyroid cancer patients when using recombinant or endogenous TSH | 1-gen-2020 | Campopiano, Maria Cristina; Podestà, Debora; Bianchi, Francesca; Giani, Carlotta; Agate, Laura; Bottici, Valeria; Cappagli, Virginia; Lorusso, Loredana; Matrone, Antonio; Puleo, Luciana; Valerio, Laura; Viola, David; Piaggi, Paolo; Elisei, Rossella; Molinaro, Eleonora | |
| OR21-01 Pre-Operative Calcitonin Value as a Predictive Factor of Cancer Related Death in Sporadic Medullary Thyroid Carcinoma | 1-gen-2020 | Matrone, A; Cappagli, V; Donati, Ds; Prete, A; Valerio, L; Giani, C; Bottici, V; Viola, D; Agate, L; Molinaro, E; Vitti, P; Elisei, R. | |
| Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up | 1-gen-2020 | Giani, C; Torregrossa, L; Piaggi, P; Matrone, A; Viola, D; Molinaro, E; Agate, L; Romei, C; Ugolini, C; De Napoli, L; Materazzi, G; Basolo, F; Elisei, R | |
| Proteinuria is a late-onset adverse event in patients treated with cabozantinib | 1-gen-2020 | Cappagli, V; Moriconi, D; Bonadio, A G; Giannese, D; La Manna, Gaetano; Egidi, M Francesca; Comai, G; Vischini, G; Bottici, V; Elisei, R; Viola, D | |
| Role Of Prophylactic Central Compartment Lymph Node Dissection On The Outcome Of Patients With Papillary Thyroid Carcinoma And Synchronous Ipsilateral Cervical Lymph Node Metastases | 1-gen-2020 | De Napoli, Luigi; Matrone, Antonio; Favilla, Karin; Piaggi, Paolo; Galleri, David; Ambrosini, Carlo Enrico; Aghababyan, Alexander; Papini, Piermarco; Valerio, Laura; Viola, David; Torregrossa, Liborio; Ugolini, Clara; Proietti, Agnese; Basolo, Fulvio; Miccoli, Paolo; Elisei, Rossella; Materazzi, Gabriele | |
| Thyroglobulin changes are highly dependent on TSH in low-risk DTC patients not treated with 131I | 1-gen-2020 | Matrone, Antonio; Faranda, Alessio; Latrofa, Francesco; Gambale, Carla; Stefani Donati, Delio; Molinaro, Eleonora; Agate, Laura; Viola, David; Piaggi, Paolo; Torregrossa, Liborio; Basolo, Fulvio; Elisei, Rossella | |
| A rare adverse event (AE) in a group of radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) patients in therapy with lenvatinib. | 1-gen-2019 | Puleo, Luciana; Giani, Carlotta; Valerio, Laura; Viola, David; Molinaro, Eleonora; Elisei, Rossella; Agate, Laura |